[go: up one dir, main page]

GB201419433D0 - Dopamine D3 receptor antagonist compounds - Google Patents

Dopamine D3 receptor antagonist compounds

Info

Publication number
GB201419433D0
GB201419433D0 GBGB1419433.6A GB201419433A GB201419433D0 GB 201419433 D0 GB201419433 D0 GB 201419433D0 GB 201419433 A GB201419433 A GB 201419433A GB 201419433 D0 GB201419433 D0 GB 201419433D0
Authority
GB
United Kingdom
Prior art keywords
dopamine
receptor antagonist
antagonist compounds
compounds
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1419433.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indivior UK Ltd
Original Assignee
RB Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RB Pharmaceuticals Ltd filed Critical RB Pharmaceuticals Ltd
Priority to GBGB1419433.6A priority Critical patent/GB201419433D0/en
Publication of GB201419433D0 publication Critical patent/GB201419433D0/en
Priority to ES15790229T priority patent/ES2883831T3/en
Priority to CN201580071094.4A priority patent/CN107108597B/en
Priority to RU2017118562A priority patent/RU2017118562A/en
Priority to EP15790229.7A priority patent/EP3212637B1/en
Priority to PCT/GB2015/053272 priority patent/WO2016067043A1/en
Priority to JP2017523340A priority patent/JP2017532364A/en
Priority to AU2015340308A priority patent/AU2015340308B2/en
Priority to BR112017009042-2A priority patent/BR112017009042B1/en
Priority to SG11201702982UA priority patent/SG11201702982UA/en
Priority to US15/522,863 priority patent/US10000477B2/en
Priority to DK15790229.7T priority patent/DK3212637T3/en
Priority to MX2017005484A priority patent/MX2017005484A/en
Priority to KR1020177014318A priority patent/KR20170090422A/en
Priority to NZ731118A priority patent/NZ731118A/en
Priority to MA040858A priority patent/MA40858A/en
Priority to CA2964103A priority patent/CA2964103C/en
Priority to IL251725A priority patent/IL251725B/en
Priority to ZA2017/02765A priority patent/ZA201702765B/en
Priority to US15/975,466 priority patent/US10239870B2/en
Priority to US16/261,206 priority patent/US10654842B2/en
Priority to IL276400A priority patent/IL276400A/en
Ceased legal-status Critical Current

Links

GBGB1419433.6A 2014-10-31 2014-10-31 Dopamine D3 receptor antagonist compounds Ceased GB201419433D0 (en)

Priority Applications (22)

Application Number Priority Date Filing Date Title
GBGB1419433.6A GB201419433D0 (en) 2014-10-31 2014-10-31 Dopamine D3 receptor antagonist compounds
CA2964103A CA2964103C (en) 2014-10-31 2015-10-30 Dopamine d3 receptor antagonist compounds
US15/522,863 US10000477B2 (en) 2014-10-31 2015-10-30 Dopamine D3 receptor antagonist compounds
MX2017005484A MX2017005484A (en) 2014-10-31 2015-10-30 Dopamine d3 receptor antagonists compounds.
RU2017118562A RU2017118562A (en) 2014-10-31 2015-10-30 Dopamine D3 Receptor Antagonist Compounds
EP15790229.7A EP3212637B1 (en) 2014-10-31 2015-10-30 Dopamine d3 receptor antagonists compounds
PCT/GB2015/053272 WO2016067043A1 (en) 2014-10-31 2015-10-30 Dopamine d3 receptor antagonists compounds
JP2017523340A JP2017532364A (en) 2014-10-31 2015-10-30 Dopamine D3 receptor antagonist compound
AU2015340308A AU2015340308B2 (en) 2014-10-31 2015-10-30 Dopamine D3 receptor antagonists compounds
BR112017009042-2A BR112017009042B1 (en) 2014-10-31 2015-10-30 COMPOUND OF FORMULA (I) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITION
SG11201702982UA SG11201702982UA (en) 2014-10-31 2015-10-30 Dopamine d3 receptor antagonists compounds
ES15790229T ES2883831T3 (en) 2014-10-31 2015-10-30 Dopamine D3 receptor antagonist compounds
DK15790229.7T DK3212637T3 (en) 2014-10-31 2015-10-30 DOPAMIN-D3 RECEPTOR ANTAGONIST COMPOUNDS
CN201580071094.4A CN107108597B (en) 2014-10-31 2015-10-30 Dopamine D3 receptor antagonist compounds
KR1020177014318A KR20170090422A (en) 2014-10-31 2015-10-30 Dopamine d3 receptor antagonist compounds
NZ731118A NZ731118A (en) 2014-10-31 2015-10-30 Dopamine d3 receptor antagonists compounds
MA040858A MA40858A (en) 2014-10-31 2015-10-30 DOPAMINE D3 RECEPTOR ANTAGONIST COMPOUNDS
IL251725A IL251725B (en) 2014-10-31 2017-04-13 Dopamine d3 receptor antagonists compounds
ZA2017/02765A ZA201702765B (en) 2014-10-31 2017-04-19 Dopamine d3 receptor antagonists compounds
US15/975,466 US10239870B2 (en) 2014-10-31 2018-05-09 Dopamine D3 receptor antagonists
US16/261,206 US10654842B2 (en) 2014-10-31 2019-01-29 Dopamine D3 receptor antagonist compounds
IL276400A IL276400A (en) 2014-10-31 2020-07-30 Dopamine d3 receptor antagonists compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1419433.6A GB201419433D0 (en) 2014-10-31 2014-10-31 Dopamine D3 receptor antagonist compounds

Publications (1)

Publication Number Publication Date
GB201419433D0 true GB201419433D0 (en) 2014-12-17

Family

ID=52118519

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1419433.6A Ceased GB201419433D0 (en) 2014-10-31 2014-10-31 Dopamine D3 receptor antagonist compounds

Country Status (1)

Country Link
GB (1) GB201419433D0 (en)

Similar Documents

Publication Publication Date Title
IL276400A (en) Dopamine d3 receptor antagonists compounds
IL252257A0 (en) Insulin receptor partial agonists
ZA201701823B (en) T cell receptors
TWI561516B (en) Substituted dihydroisoquinolinone compounds
GB201514875D0 (en) Receptor
GB201518816D0 (en) Receptor
AP2016009445A0 (en) Muscarinic receptor agonists
IL252708A0 (en) Immediate release abuse-deterrent granulated dosage forms
IL247143B (en) Novel use of sigma-1 receptor agonist compounds
GB201409044D0 (en) New compounds
PL3194670T3 (en) Device for toilets
GB201404498D0 (en) New compounds
EP3233077A4 (en) Dopamine d2 receptor ligands
GB201416444D0 (en) New compounds
EP3233799A4 (en) Dopamine d2 receptor ligands
GB201419433D0 (en) Dopamine D3 receptor antagonist compounds
GB201419430D0 (en) Dopamine D3 receptor antagonist compounds
GB201513871D0 (en) Bicyclo dopamine D3 receptor antagonists
GB201304666D0 (en) Dopamine receptor antagonist
GB201518125D0 (en) Dopamine D3 receptor antagonist having a bicyclo moiety
GB201418676D0 (en) Compounds for use
GB201409792D0 (en) Compounds for use
GB201416462D0 (en) Compound for use
GB201408759D0 (en) Compound for use
GB201416430D0 (en) New compounds

Legal Events

Date Code Title Description
S30Z Assignments for licence or security reasons

Free format text: GB1419433.6 GB1419430.2 GB1404139.6 APPLICANT RB PHARMACEUTICALS LIMITED SECURITY AGREEMENT MORGAN STANLEY SENIOR FUNDING INC.

AT Applications terminated before publication under section 16(1)